A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge

Coxsackievirus A16 (CA16) has caused worldwide epidemics of hand, foot and mouth disease (HFMD), particularly in infants and pre-school children. Currently, there are no vaccines or antiviral drugs available for CA16-associated disease. In this study, a CA16-specific monoclonal antibody (MAb) NA11F1...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Du, Ruixiao, Mao, Qunying, Hu, Yalin, Lang, Shuhui, Sun, Shiyang, Li, Kelei, Gao, Fan, Bian, Lianlian, Yang, Ce, Cui, Bopei, Xu, Longfa, Cheng, Tong, Liang, Zhenglun
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2019
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6816366/
https://ncbi.nlm.nih.gov/pubmed/30735461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1565266
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars